Discovery of a novel genomic alteration that renders leukemic cells resistant to CD19-targeted immunotherapies

被引：2
|
作者：
Ghobadi, Armin [1 ]
Landmann, Jack H. [1 ]
Carter, Alun [1 ]
Cooper, Matthew L. [1 ,3 ]
Selli, Mehmet Emrah [1 ]
Chang, Jufang [1 ]
Baker, Matthew [2 ]
Miller, Christopher A. [1 ]
Ferraro, Francesca [1 ]
Chen, David Y. [1 ]
Smith, Amanda M. [1 ]
LaValle, Taylor A. [1 ]
Duncavage, Eric J. [1 ]
Chou, Justin [4 ]
Tam, Victor [4 ]
Benoun, Joseph M. [4 ]
Nater, Jenny [4 ]
Scholler, Nathalie [4 ]
Milletti, Francesca [4 ]
Vezan, Remus [4 ]
Bot, Adrian [4 ]
Rossi, John M. [4 ]
Singh, Nathan [1 ]
机构：
[1] Washington Univ, Sch Med, Div Oncol, St Louis, MO USA
[2] Univ Texas Hlth Sci Ctr Houston, Houston, TX USA
[3] Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX USA
[4] Kite Gilead Co, Santa Monica, CA USA
来源：
BLOOD ADVANCES | 2022年 / 6卷 / 20期
关键词：
MUTATIONS; CANCER;
D O I：
10.1182/bloodadvances.2022007705
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：5634 / 5640
页数：7
相关论文
共 50 条
  • [31] CD19-Targeted T Cells Rapidly Induce Molecular Remissions in Adults with Chemotherapy Refractory Acute Leukemia
    Brentjens, Renier
    Davila, Marco L.
    Riviere, Isabelle
    Park, Jae
    Wang, Xiuyan
    Bartido, Shirley
    Stefankski, Jolanta
    Borquez-Ojeda, Oriana
    Bernal, Yvette
    Sadelain, Michel
    MOLECULAR THERAPY, 2013, 21 : S196 - S196
  • [32] Safety and tolerability of conditioning chemotherapy followed by CD19-targeted CAR T cells for relapsed/refractory CLL
    Geyer, Mark B.
    Riviere, Isabelle
    Senechal, Brigitte
    Wang, Xiuyan
    Wang, Yongzeng
    Purdon, Terence J.
    Hsu, Meier
    Devlin, Sean M.
    Palomba, M. Lia
    Halton, Elizabeth
    Bernal, Yvette
    van Leeuwen, Dayenne G.
    Sadelain, Michel
    Park, Jae H.
    Brentjens, Renier J.
    JCI INSIGHT, 2019, 4 (09)
  • [33] Donor CD19-targeted T cells exert potent graft versus lymphoma activity without GVHD
    Ghosh, Arnab
    Davila, Marco
    Young, Lauren
    Jenq, Robert
    Sadelain, Michel
    van den Brink, Marcel
    JOURNAL OF IMMUNOLOGY, 2013, 190
  • [34] Treatment of secondary CNS lymphoma using CD19-targeted chimeric antigen receptor (CAR) T cells
    Kathryn Kline
    Tim Luetkens
    Rima Koka
    Michael E. Kallen
    Wengen Chen
    Haroon Ahmad
    Destiny Omili
    Thierry Iraguha
    Etse Gebru
    Xiaoxuan Fan
    Alexis Miller
    Nishanthini Dishanthan
    Jillian M. Baker
    Kenneth A. Dietze
    Kim G. Hankey
    Jean A. Yared
    Nancy M. Hardy
    Aaron P. Rapoport
    Saurabh Dahiya
    Djordje Atanackovic
    Cancer Immunology, Immunotherapy, 73
  • [35] Treatment of secondary CNS lymphoma using CD19-targeted chimeric antigen receptor (CAR) T cells
    Kline, Kathryn
    Luetkens, Tim
    Koka, Rima
    Kallen, Michael E.
    Chen, Wengen
    Ahmad, Haroon
    Omili, Destiny
    Iraguha, Thierry
    Gebru, Etse
    Fan, Xiaoxuan
    Miller, Alexis
    Dishanthan, Nishanthini
    Baker, Jillian M.
    Dietze, Kenneth A.
    Hankey, Kim G.
    Yared, Jean A.
    Hardy, Nancy M.
    Rapoport, Aaron P.
    Dahiya, Saurabh
    Atanackovic, Djordje
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2024, 73 (03)
  • [36] CD19-Targeted Donor T Cells Exert Potent Graft Versus Lymphoma Activity and Attenuated Gvhd
    Ghosh, Arnab
    Davila, Marco L.
    Young, Lauren F.
    Kloss, Christopher
    Gunset, Gertrude
    Smith, Odette M.
    West, Mallory L.
    Singer, Natalie V.
    Holland, Amanda M.
    Jenq, Robert R.
    Hanash, Alan M.
    Dudakov, Jarrod A.
    Velardi, Enrico
    Shono, Yusuke
    Sadelain, Michel
    van den Brink, Marcel R. M.
    BLOOD, 2012, 120 (21)
  • [37] IN VIVO EXPANSION OF GAMMA DELTA T CELLS BY A CD19-TARGETED BUTYROPHILIN HETERODIMER LEADS TO ELIMINATION OF PERIPHERAL B CELLS
    De Silva, Suresh
    Fromm, George
    Gonzalez, Louis
    Patel, Arpita
    Yoon, Kyung
    Opheim, Zachery
    Farmer, Robert
    Chamberlain, Dean
    Schreiber, Taylor
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A413 - A413
  • [38] Efficacy of humanized CD19-targeted chimeric antigen receptor (CAR)-modified T cells in children with relapsed ALL
    Maude, Shannon L.
    Barrett, David Maxwell
    Rheingold, Susan R.
    Aplenc, Richard
    Teachey, David T.
    Callahan, Colleen
    Shaw, Pamela A.
    Brogdon, Jennifer
    Young, Regina
    Scholler, John
    Marcucci, Katherine
    Kulikovskaya, Irina
    Nazimuddin, Farzana
    Zheng, Zhaohui
    Levine, Bruce
    Porter, David L.
    Lacey, Simon F.
    Melenhorst, Jan Joseph
    June, Carl H.
    Grupp, Stephan A.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [39] Sustained B cell depletion by CD19-targeted CAR T cells is a highly effective treatment for murine lupus
    Kansal, Rita
    Richardson, Noah
    Neeli, Indira
    Khawaja, Saleem
    Chamberlain, Damian
    Ghani, Marium
    Ghani, Qurat-ul-ain
    Balazs, Louisa
    Beranova-Giorgianni, Sarka
    Giorgianni, Francesco
    Kochenderfer, James N.
    Marion, Tony
    Albritton, Lorraine M.
    Radic, Marko
    SCIENCE TRANSLATIONAL MEDICINE, 2019, 11 (482)
  • [40] Regulatory T cells expressing CD19-targeted chimeric antigen receptor restore homeostasis in Systemic Lupus Erythematosus
    Doglio, M.
    Ugolini, A.
    Bercher-Brayer, C.
    Camisa, B.
    Toma, C.
    Norata, R.
    Del Rosso, S.
    Greco, R.
    Ciceri, F.
    Sanvito, F.
    Casucci, M.
    Manfredi, A. A.
    Bonini, C.
    NATURE COMMUNICATIONS, 2024, 15 (01)
12345